Guidelines for the management of thyroid cancer

Clinical Endocrinology

Volumn 58, Issue 4, 2003, Pages 400-402

  Kendall Taylor, Pat ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LIOTHYRONINE; PROTEIN RET; THYROXINE;

ASPIRATION BIOPSY; CANCER RECURRENCE; EVIDENCE BASED MEDICINE; GENE MUTATION; HUMAN; LYMPH NODE DISSECTION; NOTE; PATIENT REFERRAL; PRACTICE GUIDELINE; PRIORITY JOURNAL; THYROID CANCER; THYROID MEDULLARY CARCINOMA; THYROIDECTOMY; TREATMENT INDICATION; TREATMENT PLANNING; TUMOR VOLUME;

BIOPSY, NEEDLE; CARCINOMA, MEDULLARY; HUMANS; IODINE RADIOISOTOPES; PRACTICE GUIDELINES; THYROID NEOPLASMS;

EID: 0037382237     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2003.01752.x     Document Type: Note

References (14)

1. Carlson, K.M., Bracamontes, J., Jackson, C.E. et al. (1994) Parent of origin effects in multiple endocrine neoplasia type 2B. American Journal of Human Genetics, 55, 1076-1078.
2. Coleman, P.M., Babb, P., Damiecki, P., Groslaude, P., Honjo, S., Jones, J. et al. (1999) Cancer Survival Trends in England and Wales 1971-1995: Deprivation and NHS Region (Series SMPS no. 61). Stationery Office, London: pp. 471-478.
3. Gagel, R.F., Cote, G.J., Martin Bughalo, M.J.G et al. (1995) Clinical use of molecular information in the management of multiple endocrine neoplasia type A. Journal of Internal Medicine, 238, 333-341.
4. Hardy, K.J., Walker, B.R., Lindsay, R.S., Kennedy, R.L., Seckl, J.R. & Padfield, P.L. (1995) Thyroid cancer Management. Clinical Endocrinology, 42, 651-655.
5. Kendall-Taylor, P. (2001) Thyroid cancer in the UK: can we do it better? Clinical Endocrinology, 54, 705-706.
6. Kumar, H., Daykin, J., Holder, R., Watkinson, J.C., Sheppard, M.C. & Franklyn, J.A. (2001) An audit of the management of differentiated thyroid cancer in specialist and nonspecialist clinic settings. Clinical Endocrinology, 54, 719-723.
7. Marsh, D.J., McDowall, D., Hyland, V.J. et al. (1996) The identification of false positive responses to the pentagastrin stimulation test in RET mutation negative members of MEN 2A families. Clinical Endocrinology, 44, 213-220.
8. Mazzaferri, E.L. & Jhiang, S.M. (1994) Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. American Journal of Medicine, 97, 418-428.
9. Mazzaferri, E.L. & Kloos, R.T. (2001) Clinical Review. Current approaches to primary therapy for papillary and follicular thyroid cancer. Journal of Clinical Endocrinology and Metabolism, 86, 1447-1463
10. National Health Service. (2000) Manual of Cancer Services Standards. http://www.doh.gov.uk/cancer/mcss.htm.
11. Schlumberger, M.J. (1998) Papillary and follicular thyroid carcinoma. New England Journal of Medicine, 338, 297-306.
12. Teppo, L. & Hakulinen and Eurocare Working Group (1998) Variation in survival of adult patients with thyroid cancer in Europe. European Journal of Cancer, 34, 2238-2252.
13. Vanderpump, M.P.J., Alexander, L., Scarpello, J.H.B. & Clayton, R.N. (1998) An audit of Management of thyroid cancer in a district general hospital. Clinical Endocrinology, 48, 419-424.
14. Wells, S.A., Dilley, W.G., Farndon, J.R. et al. (1985) Early diagnosis and treatment of medullary thyroid carcinoma. Archives of Internal Medicine, 145, 1248-1252.